ANDA Submissions – Prior Approval Supplements Under GDUFA: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 14, 2022
January 11, 2023
433ffd43-857c-4bec-84e3-acc6a271a04c
Related Documents
Identification of Medicinal Products — Implementation and Use
Guidance DocumentMarch 30, 2023Center for Drug Evaluation and Research
Information Requests and Discipline Review Letters Under the Generic Drug User Fee Amendments: Guidance for Industry
Guidance DocumentOctober 5, 2022Center for Drug Evaluation and Research
Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff
Guidance DocumentNovember 24, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox